213 related articles for article (PubMed ID: 28625738)
1. Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib.
Ross FA; Hawley SA; Auciello FR; Gowans GJ; Atrih A; Lamont DJ; Hardie DG
Cell Chem Biol; 2017 Jul; 24(7):813-824.e4. PubMed ID: 28625738
[TBL] [Abstract][Full Text] [Related]
2. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
3. AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.
Gowans GJ; Hawley SA; Ross FA; Hardie DG
Cell Metab; 2013 Oct; 18(4):556-66. PubMed ID: 24093679
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.
Zhu H; Moriasi CM; Zhang M; Zhao Y; Zou MH
J Biol Chem; 2013 Jun; 288(23):16495-16505. PubMed ID: 23612973
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-Induced AMP-Activated Protein Kinase Activation Is Cell-Type Dependent: Lessons from Basic Research for Clinical Application.
Lan F; Weikel KA; Cacicedo JM; Ido Y
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28708087
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells.
Willows R; Sanders MJ; Xiao B; Patel BR; Martin SR; Read J; Wilson JR; Hubbard J; Gamblin SJ; Carling D
Biochem J; 2017 Aug; 474(17):3059-3073. PubMed ID: 28694351
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
Groenendijk FH; Mellema WW; van der Burg E; Schut E; Hauptmann M; Horlings HM; Willems SM; van den Heuvel MM; Jonkers J; Smit EF; Bernards R
Int J Cancer; 2015 Mar; 136(6):1434-44. PubMed ID: 25080865
[TBL] [Abstract][Full Text] [Related]
8. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
[TBL] [Abstract][Full Text] [Related]
9. CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines.
Ma Y; Yang F; Wang Y; Du Z; Liu D; Guo H; Shen J; Peng H
PLoS One; 2012; 7(10):e47900. PubMed ID: 23110126
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibitory effects of two Raf-targeting drugs, sorafenib and PLX4720, on the growth of multidrug-resistant cells.
Eum KH; Ahn SK; Kang H; Lee M
Mol Cell Biochem; 2013 Jan; 372(1-2):65-74. PubMed ID: 22941213
[TBL] [Abstract][Full Text] [Related]
11. Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (Pseudo)kinases upon Binding Small Molecules.
Di Michele M; Stes E; Vandermarliere E; Arora R; Astorga-Wells J; Vandenbussche J; van Heerde E; Zubarev R; Bonnet P; Linders JT; Jacoby E; Brehmer D; Martens L; Gevaert K
J Proteome Res; 2015 Oct; 14(10):4179-93. PubMed ID: 26293246
[TBL] [Abstract][Full Text] [Related]
12. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1.
Yamada E; Pessin JE; Kurland IJ; Schwartz GJ; Bastie CC
Cell Metab; 2010 Feb; 11(2):113-24. PubMed ID: 20142099
[TBL] [Abstract][Full Text] [Related]
13. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells.
Xie Z; Dong Y; Zhang M; Cui MZ; Cohen RA; Riek U; Neumann D; Schlattner U; Zou MH
J Biol Chem; 2006 Mar; 281(10):6366-75. PubMed ID: 16407220
[TBL] [Abstract][Full Text] [Related]
14. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation.
Zhang YL; Guo H; Zhang CS; Lin SY; Yin Z; Peng Y; Luo H; Shi Y; Lian G; Zhang C; Li M; Ye Z; Ye J; Han J; Li P; Wu JW; Lin SC
Cell Metab; 2013 Oct; 18(4):546-55. PubMed ID: 24093678
[TBL] [Abstract][Full Text] [Related]
15. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
Thors B; Halldórsson H; Thorgeirsson G
Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
[TBL] [Abstract][Full Text] [Related]
16. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.
Sanders MJ; Grondin PO; Hegarty BD; Snowden MA; Carling D
Biochem J; 2007 Apr; 403(1):139-48. PubMed ID: 17147517
[TBL] [Abstract][Full Text] [Related]
17. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Fyn SH3 domain interaction with a proline-rich motif in liver kinase B1 results in activation of AMP-activated protein kinase.
Yamada E; Bastie CC
PLoS One; 2014; 9(2):e89604. PubMed ID: 24586906
[TBL] [Abstract][Full Text] [Related]
19. Fake Inhibitors: AMPK Activation Trumps Inhibition.
Langendorf CG; Scott JW; Kemp BE
Cell Chem Biol; 2017 Jul; 24(7):775-777. PubMed ID: 28732195
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
